SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein | 21-801

SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein | 21-801 | Gentaur UK, US & Europe Distribution

Tested Application: N/A

Application: Immunogen

Tpredicted Molecular Weight: N/A

Physical State: Lyophilized

Buffer: Supplied as lyophilized from PBS, pH 7.5. Please reconstitute the protein with ddH2O to the concentration with 1mg/ml.

Storage Condition: Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 2 to 8 ˚C for one week .Store at -20 to -80 ˚C for twelve months from the date of receipt.

Alternate Name: Spike,S protein RBD,Spike glycoprotein Receptor-binding domain,S glycoprotein RBD,Spike protein RBD

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: Mammalian cells

Species: SARS-CoV-2

By Source: Human Cells

By Species: Other

Fusion Tag: His Tag

Sequence: RBD with mutations at G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H.

Bological Activity: N/A

Purity: >90% as determined by SDS-PAGE